Clinical Trial Update: Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

View source ↗

Summary

This clinical trial update reports long-term outcomes of treating chronic kidney disease patients with paricalcitol in German and Austrian clinical practice; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Zemplar (Paricalcitol)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Kidney Insufficiency, Secondary Hyperparathyroidism | Status: COMPLETED | Results posted: 2014-12-19